Supplement
Inositol is a sugar-like compound the body makes that helps cells respond to insulin and relay signals. Most people look at it for polycystic ovary syndrome (PCOS), where the evidence is strong overall, and trials found blood glucose improved and acne symptoms eased. Still, the glucose result came from two small studies and the acne result from one trial of 50 women.
Sources: PMID 36703143; PMID 19551544; PMID 22774396
- Updated
- How we grade
- 55 studies cited
- Best evidence
- Grade B
- Conditions studied
- 28
- Outcomes
- 102
- Graded outcomes
- 03116
Evidence by condition
- Strong
- Moderate
- Limited
- Very limited
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anxiety Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 3 studies | 41 people | ||
| Panic Attacks | Improves (the measure goes down) | 1 study | 53 people | |||
Studies that measured panic attacks | ||||||
Metabolic Syndrome
- Blood glucose: improves
- Weight: improves
- Glycemic Control: improves
Overweight
- Glycemic Control: improves
- Insulin: changes; see studies
- PCOS Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Glycemic Control Small Improvement | Improves (the measure goes up) | Small effect | 4 studies | 20 people | ||
Studies that measured glycemic control
| ||||||
| Insulin | Changes; see studies | 1 study | 20 people | |||
| PCOS Symptoms | Improves (the measure goes down) | 20 people | ||||
Infertility
- Fertility: improves
- Oocyte Quality: improves
- Oocyte Quantity: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Fertility Small Improvement | Improves (the measure goes up) | Small effect | 3 studies | 184 people | ||
Studies that measured fertility
| ||||||
| Oocyte Quality | Improves (the measure goes up) | 84 people | ||||
| Oocyte Quantity | Improves (the measure goes up) | 100 people | ||||
| PCOS Symptoms | Improves (the measure goes down) | 184 people | ||||
Agoraphobia
- Anxiety Symptoms: improves
- Panic Attacks: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anxiety Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 3 studies | 21 people | ||
| Panic Attacks | Improves (the measure goes down) | 1 study | 21 people | |||
Studies that measured panic attacks | ||||||
Binge Eating Disorder
- Anxiety Symptoms: improves
- Depression Symptoms: improves
- Binge-eating: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anxiety Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 3 studies | 24 people | ||
| Depression Symptoms | Improves (the measure goes down) | 5 studies | 24 people | |||
Studies that measured depression symptoms
| ||||||
| Binge-eating | Improves (the measure goes up) | 24 people | ||||
Obsessive-Compulsive disorder (OCD)
- Anxiety Symptoms: improves
- Depression Symptoms: improves
- OCD Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Anxiety Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 3 studies | 13 people | ||
| Depression Symptoms | Improves (the measure goes down) | 5 studies | 13 people | |||
Studies that measured depression symptoms
| ||||||
| OCD Symptoms | Improves (the measure goes down) | 1 study | 13 people | |||
Studies that measured ocd symptoms | ||||||
High Cholesterol
- Blood glucose: improves
- Weight: improves
- Triglycerides: improves
Menopause
- Blood glucose: improves
- Weight: improves
- Glycemic Control: improves
Obesity
- Blood glucose: improves
- Weight: improves
- Glycemic Control: improves
Hirsutism
- Blood glucose: improves
- Excessive Hair Growth: improves
- Insulin: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 2 studies | 46 people | ||
| Excessive Hair Growth | Improves (the measure goes up) | 1 study | 46 people | |||
Studies that measured excessive hair growth | ||||||
| Insulin | Changes; see studies | 1 study | 46 people | |||
Gestational Diabetes
- Adiponectin: improves
- Glycemic Control: improves
- Blood glucose: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Adiponectin Small Increase | Improves (the measure goes up) | Small effect | 69 people | |||
| Glycemic Control | Improves (the measure goes up) | 4 studies | 1,321 people | |||
| Blood glucose | Improves (the measure goes down) | 2 studies | 142 people | |||
| Gestational Diabetes Risk | Changes; see studies | 1 study | 1,321 people |
Schizophrenia
- Depression Symptoms
- Schizophrenia symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Depression Symptoms No effect | NoneNo effect | 5 studies | 21 people | |||
| Schizophrenia symptoms | Improves (the measure goes down) | 2 studies | 44 people |
Premenstrual Dysphoric Disorder (PMDD)
- Depression Symptoms
- PMS Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Depression Symptoms No effect | NoneNo effect | 5 studies | 71 people | |||
| PMS Symptoms | Improves (the measure goes down) | 1 study | 82 people |
Premenstrual Syndrome (PMS)
- Depression Symptoms
- PMS Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Depression Symptoms No effect | NoneNo effect | 5 studies | 71 people | |||
| PMS Symptoms | Improves (the measure goes down) | 1 study | 71 people |
Depression
- Bipolar Disorder Symptoms
- Depression Symptoms: improves
- Schizophrenia symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Bipolar Disorder Symptoms No effect | NoneNo effect | 1 study | 66 people | |||
| Depression Symptoms | Improves (the measure goes down) | 5 studies | 113 people | |||
| Schizophrenia symptoms | Improves (the measure goes down) | 2 studies | 21 people |
Bipolar Disorder
- Bipolar Disorder Symptoms
- Depression Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Bipolar Disorder Symptoms No effect | NoneNo effect | 1 study | 24 people | |||
| Depression Symptoms | Improves (the measure goes down) | 5 studies | 24 people |
Dyslipidemia
- High-density lipoprotein (HDL)
- Triglycerides: improves
- Low-density lipoprotein (LDL): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| High-density lipoprotein (HDL) No effect | NoneNo effect | 757 people | ||||
| Triglycerides | Improves (the measure goes down) | 1 study | 819 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 346 people | ||||
| Total cholesterol | Improves (the measure goes down) | 819 people |
Alzheimer’s Disease
- Alzheimer's Disease Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Alzheimer's Disease Symptoms | Improves (the measure goes down) | 2 studies | 177 people |
Alzheimer’s Disease
- Alzheimer's Disease Symptoms: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Alzheimer's Disease Symptoms | Changes; see studies | 2 studies | 177 people |
Autism Spectrum Disorder (ASD)
- Autism Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Autism Symptoms | Improves (the measure goes down) | 1 study | 9 people |
Psoriasis
- Psoriasis Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Psoriasis Symptoms | Improves (the measure goes down) | 1 study | 15 people |
Cognitive Improvement
- Forgetting: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Forgetting | Improves (the measure goes up) | 1 study | 12 people |
Infant Health
- Retinal Function: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Retinal Function | Improves (the measure goes up) | 1 study | 898 people |
Lung Cancer
- Lung Cancer Risk: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Lung Cancer Risk | Changes; see studies | 1 study | 10 people |
Premature Birth
- Gestational Diabetes Risk: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Gestational Diabetes Risk | Changes; see studies | 1 study | 83 people |
Post-Traumatic Stress Disorder (PTSD)
- Post-Traumatic Stress Disorder Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Post-Traumatic Stress Disorder Symptoms | Improves (the measure goes down) | 1 study | 12 people |
What the published studies found
1 automated reading
Sleep quality
The studies read are too weak to tell whether Inositol changes sleep quality. They lean toward an improvement, which is not enough to claim one. The evidence is very weak.
1 study counted of 4 read: 1 trial (60 people in the trials).
- Randomised trial, 2022; 60 people; pregnant women with low-risk singleton pregnancies: improves.
mean difference of the total sleep quality score between the two groups was -1.537
The impact of myo-inositol supplementation on sleep quality in pregnant women: a randomized, double-blind, placebo-controlled study
- Randomised trial, 2022; 60 people; pregnant women with low-risk singleton pregnancies: improves.
Key findings
- Anxiety SymptomsImproves (the measure goes down)
- Blood glucoseImproves (the measure goes down)
- Glycemic ControlImproves (the measure goes up)
Shop the evidence-backed picks
Third-party tested Inositol products, in the forms the graded studies used where we can match them.
- Grade B
Links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Fullscript asks for a free account before it shows its catalog and prices. Full disclosure
Studies cited
55 studies from PubMed
- Myo-Inositol in Patients with PCOS: A Systematic Review and Meta-Analysis
- Myo-Inositol and D-Chiro-Inositol in PCOS Treatment: A Meta-Analysis
- Inositol and Insulin Resistance: Mechanisms and Clinical Evidence
- Inositol and Depression: A Systematic Review
- Inositol and PCOS: A Comprehensive Review of Clinical Evidence
- Inositol in Anxiety Disorders: A Systematic Review
- Myo-Inositol in Gestational Diabetes: A Meta-Analysis
- Inositol and Fertility: A Comprehensive Review
- Safety and Efficacy of Inositol in Clinical Practice: A Review
- Inositol Effects on Metabolic Syndrome: A Systematic Review
- The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone
- Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial
- Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients
- Inositol administration reduces oxidative stress in erythrocytes of patients with polycystic ovary syndrome
- Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome
- Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial
- Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome
- Pharmacological and Non-Pharmacological Interventions for Polycystic Ovary Syndrome (PCOS) in Indian Women: A Systematic Review and Meta-Analysis.
- Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials.
- Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial
- Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial
- Myo-inositol may prevent gestational diabetes in PCOS women
- Inositol for subfertile women with polycystic ovary syndrome.
- Myo-inositol treatment increases serum plasmalogens and decreases small dense LDL, particularly in hyperlipidemic subjects with metabolic syndrome
- One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome
- A phase I study of myo-inositol for lung cancer chemoprevention
- Treatment of hirsutism with myo-inositol: a prospective clinical study
- Inositol for depressive disorders.
- Double-blind, controlled trial of inositol treatment of depression
- Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone
- Inositol addition does not improve depression in SSRI treatment failures
- Effect of inositol on bulimia nervosa and binge eating
- Inositol Nutritional Supplementation for the Prevention of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes
- Dietary supplementation with myo-inositol in women during pregnancy for treating gestational diabetes.
- A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease
- Inositol treatment of Alzheimer's disease: a double blind, cross-over placebo controlled trial
- Lack of effect of inositol treatment in chronic schizophrenia
- CSF inositol in schizophrenia and high-dose inositol treatment of schizophrenia
- Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder
- Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder
- Acute inositol does not attenuate m-CPP-induced anxiety, mydriasis and endocrine effects in panic disorder
- Myo-inositol in the treatment of premenstrual dysphoric disorder
- Myo-inositol has no beneficial effect on premenstrual dysphoric disorder
- Inositol as an add-on treatment for bipolar depression
- Inositol treatment of autism
- Inositol treatment of obsessive-compulsive disorder
- Inositol treatment of post-traumatic stress disorder
- Lack of effect of 6 g inositol treatment of post-ECT cognitive function in humans
- The effect of inositol supplements on the psoriasis of patients taking lithium: a randomized, placebo-controlled trial
- Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study
- The effects of inositol supplementation on lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials.
- The efficacy and safety of inositol supplementation in preterm infants to prevent retinopathy of prematurity: a systematic review and meta-analysis.